Generic Drugmakers to Sell Pfizer's Paxlovid US$ 25 or Less in Low-income Countries
Kamis, 12 Mei 2022 | 21:15 WIB
KONTAN.CO.ID - NEW YORK. Several generic drugmakers that will produce versions of Pfizer's Covid-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for US$ 25 a course or less. The Clinton Health Access Initiative (CHAI) said on Thursday.
CHAI said it could not disclose the names of the manufacturers who have agreed to the price ceiling. Because, they are still in the early stage of product development and have not received regulatory approval.
Ini Artikel Spesial
Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan.
Sudah Berlangganan? Masuk
Berlangganan dengan Google
Gratis uji coba 7 hari pertama dan gunakan akun Google sebagai metode pembayaran.
Business Insight
Artikel pilihan editor Kontan yang menyajikan analisis mendalam, didukung data dan investigasi.
Kontan Digital Premium Access
Paket bundling Kontan berisi Business Insight, e-paper harian dan tabloid serta arsip e-paper selama 30 hari.
Masuk untuk Melanjutkan Proses Berlangganan
